Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

The magazine 'Ronda Iberia' highlights VHIR as a reference in research

It explains the studies of human microbiome, diabetic retinopathy and endometrium cancer

News

Dr. Lleonart talks about Nobel Prize in Medicine 2012

John B. Gurdon and Shinya Yamanaka discovered that mature cells can be reprogrammed into stem cells

News

VHIR proposes a new approach for the use of antiaggregants in patients with pharmaco-active stents

VHIR researchers present the results and deserve an editorial at JACC

News

Dr. Patricia Pozo debates about migraine at TVE

VHIR's researcher explains how the predisposition to this disease has a genetic base

News

Dr. Mercè Boada wins Josep Trueta Award

Dr. Josep Baselga from VHIO also received the medal

News

Vall d'Hebron participates in EuSOS, study that investigates mortality after surgery in Europe

The results of this research were published recently in 'The Lancet'

News

Dr. Montaner reports about stroke research in a chat

He answered doubts and clarified concepts at DKV Diálogos

News

Roche's Head of Applied Science visits VHIR

Meeting with VHIR's director and members of the research group in liver diseases at the facilities of the institute.

News

Dr. Petriz in the cycle of Basic and Advanced Cytometry

The aim of the sessions was to provide basic and advanced training in flow cytometry.

News

Dementia Symposium in the Alzheimer World Day at Vall d'Hebron

This year has been focused on the update on the diagnosis and the managing of Alzheimer disease.

News

Lancet Neurology highlights Dr. Montalban's profile

Describes the head of the Clinical Neuroimmunology group at VHIR as a 'pioneer in understanding multiple sclerosis'.

News

Forty experts of European and American universities meet at Vall d'Hebron to discuss about the future of MS

Genetics, immunology, diagnosis and therapies were some of the aspects treated in the presentations.

News

Vall d’Hebron disminueix la mortalitat per sèpsia gairebé la meitat en sis anys

Celebració Mundial del Dia de la Sèpsia el 13 setembre.

News

Exercise, alcohol or antiinflammatory are determinant to activate some food allergies

The work emphasizes the importance of evaluating these factors while treating patients with allergic food reactions.

News

VHIR leads a project that searchs biomarkers to detect prematurely ovarian cancer

The project will also use all the resources to determine biomarkers of response to the chemotherapy.

News

Vall d'Hebron leads an international project to improve the treatment of Chagas's disease

Chagas's disease is a chronic one caused by a parasite, Trypasonoma cruzi.

News

Plenary Conference of Dr. Reventós in the Centennial Congress of the Catalan Society of Biology

"Our main aim is to improve the early detection of hormo-dependent cancers".

News

Startup of the Barcelona Alzheimer Neuroimage Group (BANG) with the collaboration of VHIR

For research in neuroimage and other biomarkers of degenerative neuronal diseases as Alzheimer.

News

CIBBIM participates in the Nanotechnology for Healthcare Forum

Dr. Simó Schwartz, coordinator of the Molecular Biology and Biochemistry Research Centre for Nanomedicine–CIBBIM- at Vall d'Hebron Research Institute (VHIR). Dr. Schwartz' participated on July 10th in the Nanotechnology for Healthcare Forum, meeting organized by Biocat and UK Trade & Investment-Brit

News

Joan Comella: 'We try to return to society with science and advances the money that they invest in us'

On Sunday 8th of July Dr. Joan Comella, director of Vall d'Hebron Research Institute (VHIR) was invited at the show 'Eureka' of ComRadio with occasion of the cycle of interviews with the directors of different research centers from Catalonia. During the interview he answered about the last discoveri